SB 350 (2018): relative to biological products dispensed by pharmacists.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA
“SB 350 (2018): relative to biological products dispensed by pharmacists.” Granite Record, https://graniterecord.org/bill/2018/sb350. Accessed 24 Oct. 2026.
APA
Granite Record. (n.d.). SB 350 (2018): relative to biological products dispensed by pharmacists. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2018/sb350
Chicago
Granite Record. “SB 350 (2018): relative to biological products dispensed by pharmacists.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2018/sb350.
BibTeX
@misc{bill-2018-sb350, title = {SB 350 (2018): relative to biological products dispensed by pharmacists.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2018/sb350}, note = {Accessed 24 Oct. 2026} }

SB 350 (2018)

relative to biological products dispensed by pharmacists.

  • Status: Referred for interim study
  • Term: 2017-2018
  • House committee: Health, Human Services and Elderly Affairs
  • Senate committee: Health and Human Services
  • Subject: Occupational Regulation

The Story

It was introduced on January 3, 2018 and referred to the Senate Health and Human Services committee. The committee held a public hearing on March 13, 2018. The committee voted unanimously, 5–0, to recommend that the Senate pass it with changes (amendment 2018-1096s), and the report was placed on the consent calendar. On March 21, 2018 the Senate adopted “Special Order to 03/22/2018, Without Objection”. The committee recommended that the Senate pass it with changes (amendment 2018-1096s). The committee's amendment (2018-1096s) was adopted on a voice vote on March 22, 2018, changing the text of the bill. A floor amendment (2018-1125s), offered by Sen. Bradley, was adopted on a voice vote on March 22, 2018, changing the text of the bill. On March 22, 2018 the Senate voted to pass it with changes on a voice vote and ordered it to a third reading. It crossed to the House on March 22, 2018 and was referred to the House Health, Human Services and Elderly Affairs committee. The committee held a public hearing on April 11, 2018. The committee met in executive session on April 17, 2018 to vote on its recommendation. The minority of the committee recommended that the House pass it with changes (amendment 2018-1523h). The majority of the committee recommended that the House study it after the session ends by a vote of 16–7, and the report was placed on the regular calendar. On April 26, 2018 the House voted to study it after the session ends on a voice vote. The committee met in executive session on October 16, 2018 to vote on its recommendation. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 17 to 0.

Sponsors

Hearings and Sessions

  • March 13, 2018, 1:00 PM: hearing, Senate Health and Human Services, LOB 101
  • April 11, 2018, 10:00 AM: public hearing, House Health, Human Services and Elderly Affairs, LOB 206
  • April 17, 2018, 10:00 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 205
  • October 16, 2018, 1:00 PM: executive session, House Health, Human Services and Elderly Affairs, LOB205

Votes

  • March 22, 2018, Senate: Ought to Pass with Amendment s 2018-1096s and 2018-1125s — voice vote, passed
  • April 26, 2018, House: Refer for Interim Study — voice vote, passed

The Docket

  • January 3, 2018: To Be Introduced 01/03/2018 and Referred to Health and Human Services
  • March 13, 2018: Hearing: 03/13/2018, Room 101, LOB, 01:00 pm
  • March 21, 2018: Committee Report: Ought to Pass with Amendment #2018-1096s , 03/21/2018; Vote 5-0; CC
  • March 21, 2018: Sen. Bradley Moved to Remove SB 350 from the Consent Calendar; 03/21/2018
  • March 21, 2018: Special Order to 03/22/2018, Without Objection, MA; 03/21/2018
  • March 22, 2018: Committee Report: Ought to Pass with Amendment #2018-1096s , 03/22/2018
  • March 22, 2018: Committee Amendment #2018-1096s , AA, VV; 03/22/2018
  • March 22, 2018: Sen. Bradley Floor Amendment #2018-1125s , AA, VV; 03/22/2018
  • March 22, 2018: Ought to Pass with Amendment s 2018-1096s and 2018-1125s, MA, VV; OT3rdg; 03/22/2018
  • March 22, 2018: Introduced 03/22/2018 and referred to Health, Human Services and Elderly Affairs
  • April 11, 2018: Public Hearing: 04/11/2018 10:00 AM LOB 206
  • April 17, 2018: Executive Session: 04/17/2018 10:00 AM LOB 205
  • April 18, 2018: Minority Committee Report: Ought to Pass with Amendment #2018-1523h
  • April 26, 2018: Majority Committee Report: Refer for Interim Study for 04/26/2018 (Vote 16-7; RC)
  • April 26, 2018: Refer for Interim Study: MA VV 04/26/2018
  • October 16, 2018: Executive Session: 10/16/2018 01:00 PM LOB205
  • October 29, 2018: Interim Study Report: Not Recommended for Future Legislation (Vote 17-0)

Laws It Would Change

Related Bills

  • HB 1791-FN (2018): allowing pharmacists to disclose information relative to lower cost drugs under the managed care law and relative to biological products dispensed by pharmacists.
  • HB 1791-FN (2018): allowing pharmacists to disclose information relative to lower cost drugs under the managed care law and relative to biological products dispensed by pharmacists.

From the General Court